MedTrace Logo

MELCAYA - Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults - Work Package 3 (WP3)

NCT06602648 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-09-19

No results posted yet for this study

Summary

The aim of this study is to investigate a type of skin cancer, also known as melanoma, in children, adolescents, and young adults, who will be referred to as CAYA patients in this project. The need for this study arises because this disease, in CAYA patients, is still poorly understood due to its rarity in individuals under 30 years old. This often leads to difficulties in assessing its severity and, consequently, in deciding on the necessary treatments to ensure the patient\'s recovery. The goal of this study is to examine melanoma in CAYA patients in order to gather the information needed to provide better diagnoses for affected patients and, as a result, select appropriate treatments to fight the disease and promote the patient\'s full recovery. Additionally, the data collected will be used to create a Pan-European online platform that will allow doctors across the European Union to consult the obtained data and collaborate on particularly complex melanoma cases, always with the aim of ensuring the patient\'s full recovery in the shortest possible time.

Conditions

  • Melanoma of Skin

Sponsors & Collaborators

  • Tubingen University Hospital

    collaborator UNKNOWN

  • Maria Sklodowska-Curie National Research Institute of Oncology

    collaborator OTHER

  • Fondazione IRCCS ISTITUTO NAZIONALE TUMORI

    collaborator UNKNOWN

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • Istanbul University

    collaborator OTHER

  • University Of Perugia

    collaborator OTHER

  • German Cancer Research Center

    collaborator OTHER

  • University of Florence

    lead OTHER

Principal Investigators

  • Massi Daniela · University of Florence (UNIFI)

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-17
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06602648 on ClinicalTrials.gov